Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-15 Option Award | 2023-02-17 7:23 pm | N/A 2033-02-14 | AN2 Therapeutics Inc. | ANTX | Nazak Michael Adrian Chief Accounting Officer | 16,600 | $0 | 16,600 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 9:21 pm | N/A 2032-05-11 | AN2 Therapeutics Inc. | ANTX | Nazak Michael Adrian Chief Accounting Officer | 14,300 | $0 | 14,300 (Direct) | View |
Ownership | 2022-03-24 9:23 pm | N/A 2031-08-18 | AN2 Therapeutics Inc. | ANTX | Nazak Michael Adrian Chief Accounting Officer | 0 | $0 | 65,882 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 8:08 pm | N/A 2031-02-18 | Aridis Pharmaceuticals Inc. | ARDS | Nazak Michael Adrian Chief Financial Officer | 20,000 | $0 | 80,000 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-13 4:02 pm | N/A 2030-01-02 | Aridis Pharmaceuticals Inc. | ARDS | Nazak Michael Adrian Chief Financial Officer | 20,000 | $0 | 60,000 (Direct) | View |
Ownership | 2020-01-13 3:47 pm | N/A 2028-12-05 | Aridis Pharmaceuticals Inc. | ARDS | Nazak Michael Adrian Chief Financial Officer | 0 | $0 | 40,000 (Direct) | View |